(Daily Signal)—For years, pharmaceutical executives have insisted that drug prices are out of their hands. Government red tape, research costs, and reimbursement rules are all offered as explanations for why Americans pay more at the pharmacy counter than anyone else in the developed world.
It’s a tidy narrative. It’s also only half-true—pharma could easily drop its prices. But government has ensured that it has little reason to do so.
In a functioning market, companies charge what the market will bear. Those prices typically lower over time due to innovation, competition, and other factors. In only a few industries has the opposite happened—housing, higher education, and health care—all industries where incentives are skewed by government policies.
In the pharmaceutical industry, many factors create market disincentives. For example, U.S. taxpayers contribute roughly $17 billion each year to early-stage research and clinical studies, yet companies still price their products as if every cost rests solely on their own books. In most industries, a subsidy of that size would reduce the final price of a product. In pharmaceuticals, it has done the opposite.
Then there’s the government-guaranteed demand. Schools and the military require routine vaccinations, while federal insurance programs cover millions of prescriptions. These are not competitive markets. They are compelled markets where suppliers face little risk of losing large blocks of customers.
Whenever demand is guaranteed by federal or state policy, the incentive to price competitively weakens. A market that cannot walk away is a market that pays more.
Finally, we have patent abuse, where pharmaceutical companies create virtual monopolies by extending patents for critical and life-saving drugs again and again (and again), far beyond reason and beyond what many patients can afford.
Most industries do not enjoy this combination of subsidized research and guaranteed large scale buyers. A restaurant chain cannot rely on federal dollars to cover its early expansion. A tech startup cannot demand that public schools purchase its software. An airline cannot treat government agencies as automatic customers who have no alternative suppliers.
They all compete in markets where price is constrained by consumer choice and competitive pressure.
The irony is that pharma companies are behaving exactly as economic theory predicts. Again, students complain about high college prices—but they keep going up because of government loan, scholarship, and other policies that bring in billions as long as students can be convinced to sign the dotted line.
The same is true in housing, where well-intentioned government homeownership goals have created poor incentives for lenders and buyers alike (see the 2007 financial crash for an example of what happens when those incentive-created bubbles eventually pop).
The problem is not that companies follow incentives. The problem is that the incentives in the pharma market are distorted by public policy choices that tilt the field in one direction.
The lesson for policymakers and the public is straightforward. If we want a drug market that behaves like a market, we must design one. That means aligning research incentives with affordability and rethinking mandates that guarantee revenue without requiring accountability.
A firm’s first obligation is to its owners. If the structure of a market allows it to raise prices, reduce competition or shield revenue, the firm is expected to pursue those advantages.
And there is nothing inherently wrong with companies pursuing profit. But there is something wrong with a system that shields them from the competitive forces that keep other industries honest.
When companies say they can’t lower prices, it usually means that they simply don’t want to. But prices are choices made by all market players—such as consumers, manufacturers, and government regulators.
The sooner we acknowledge that prices are not set in stone, the sooner Americans can stop footing the bill for a pharmaceutical system that pretends otherwise.
For Emergency Preparedness, Don’t Forget the Meds
Being prepared is more than just a good idea—it’s essential. We stock up on non-perishable food, bottled water, flashlights, and first-aid supplies, but one critical aspect often gets overlooked: access to vital medications. What happens if pharmacies close, prescriptions can’t be filled, or you’re cut off from medical care during an emergency?
That’s where Jase Medical steps in, offering a reliable solution to ensure you and your family have the medications you need when it matters most.
Jase Medical specializes in emergency preparedness kits designed to provide peace of mind through physician-reviewed, prescription medications delivered right to your door. Their flagship product, the Jase Case, is a comprehensive emergency antibiotic and medication kit priced at $289.95.
This kit includes 10 essential medications—five life-saving antibiotics and five symptom relief meds—that can treat over 50 common infections and illnesses, from urinary tract infections and pneumonia to skin infections and traveler’s diarrhea. With 28 add-on options available, you can customize the kit to fit your specific needs, including a KidCase for children ages 2-11.
The process is straightforward and hassle-free. Simply visit Patriot.tv/meds, complete an online evaluation, and have your order reviewed by a board-certified physician. Once approved, the medications are shipped discreetly from a licensed pharmacy to your U.S. address (with plans for Canada shipping coming soon). Each kit comes with detailed Med Cards outlining symptoms, dosing, and usage, making it easy to administer even in high-stress situations. These medications are shelf-stable and designed for long-term storage, empowering you to handle medical emergencies without relying on external help.
For those on the move, Jase Medical also offers the Jase Go kit for $129.95, a compact travel med kit covering over 30 common conditions encountered during adventures or trips. And for ongoing needs, Jase Daily provides an extended supply of your prescribed chronic medications to safeguard against disruptions in supply chains or extreme weather events.
Don’t just take our word for it—thousands of satisfied customers have given Jase Medical a 4.9-star rating, praising its role in true preparedness. As radio host Glenn Beck warns, “The supply lines for antibiotics already are stressed to the max. Please have some antibiotics on hand… You can do it through Jase.”
Whether you’re prepping for a hurricane, a power outage, or simply the uncertainties of daily life, Jase Medical ensures you’re not caught off guard. Head to patriot.tv/meds today to customize and order your emergency kit—because when it comes to your health and safety, it’s better to be prepared than sorry.